ZURICH (Reuters) – Drugmaker Roche on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug Administration for a test to quickly detect whether a patient has SARS-CoV-2 or one of two forms of influenza
{iframe}https://www.reuters.com/article/health-coronavirus-roche-hldg-idUSKBN25V0QE{/iframe}